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I n t r o d u c t i o n
Colic remains a major cause of illness and death in the horse (1,2). 
Acute abdominal disease can lead to the sequestration of fluid in 
the obstructed bowel, inducing hypovolemic shock. Strangulation 
obstruction of the small or large intestine will disrupt the mucosal 
barrier, favoring lipopolysaccharide leakage into the general circula-
tion and resulting in endotoxemia (3,4).
Circulating lipopolysaccharides can activate neutrophils (5,6) 
or stimulate monocytes to release mediators contributing to the 
development of endotoxic shock. Ischemia–reperfusion phenom-
ena in the intestine may exacerbate the cellular injury, with the 
consequence of excessive neutrophil accumulation and activation 
(7). With excessive intravascular neutrophil activation, injury to 
organs other than the compromised bowel may occur, leading to 
organ dysfunction and failure (8), which explains the high mortality 
rate.
The stimulation of polymorphonuclear neutrophils results in 
a sudden increase in oxygen consumption, with the production 
of reactive oxygen species and the release of enzymes such as 
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A b s t r a c t
Gastrointestinal disorders, especially strangulating intestinal obstructions, are still a major cause of illness and death in the horse. 
Circulating lipopolysaccharides may activate both neutrophils and monocytes. The activated neutrophils release myeloperoxidase 
(MPO), a specific enzyme with strong oxidative activity. The aim of this study was to evaluate MPO concentrations in the plasma 
and peritoneal fluid (PF) of horses with colic and to check the hypothesis that these concentrations would be higher in a case of 
strangulating obstruction than in cases of nonstrangulating disease. By using a specific enzyme-linked immunosorbent assay for 
equine MPO, we determined the MPO concentrations in horses admitted to a clinic for colic. Horses with nonstrangulating or 
strangulating obstruction of the large intestine (NSLI or SLI), strangulating obstruction of the small intestine (SSI), or inflammatory 
bowel disease (IBD) were compared with healthy horses. The horses with SLI, SSI, or IBD had significantly higher MPO levels 
in plasma and PF than did those in the other 2 groups. The mean plasma level was significantly higher in the horses with NSLI 
than in the healthy horses. High MPO values in PF indicated necrotic bowel. These results show that neutrophil activation occurs 
during nonstrangulating and strangulating intestinal obstruction in horses and that the plasma and PF MPO concentrations 
may be a marker of the severity of the disease.
Résumé
Les pathologies intestinales du cheval, en particulier les obstructions étranglées, sont toujours une cause majeure de morbidité et de mortalité 
chez le cheval. A côté de l’activation des monocytes via les lipopolysaccharides, une activation des neutrophiles se produit également. Le 
neutrophile activé relargue la myéloperoxidase (MPO), une enzyme spécifique qui a une activité oxidative puissante. Le but de l’étude est 
d’évaluer le taux de MPO du plasma et du liquide péritonéal chez des chevaux en coliques à l’admission. L’hypothèse est que les taux de MPO 
sont plus importants en cas d’obstruction étranglée par rapport à l’obstruction simple. En utilisant un test de dosage immunoenzymatique 
spécifique de la MPO équine, les auteurs ont déterminé les taux de MPO dans le plasma et le liquide péritonéal des chevaux admis pour 
colique en clinique. Quatre groupes de chevaux ont été étudiés et comparés aux chevaux sains : des chevaux avec obstruction non-étranglée 
ou étranglée du gros intestin, obstruction étranglée de l’intestin grêle, et pathologie intestinale de type inflammatoire. Les chevaux avec 
pathologie étranglée et inflammatoire présentent des taux de MPO du plasma et du liquide péritonéal significativement plus élevés que les 
chevaux avec pathologie non-étranglée et les sains. Les valeurs de MPO plasmatique sont significativement plus élevées chez les chevaux 
avec pathologie non-étranglée par rapport aux chevaux sains. Des valeurs élevées de MPO dans le liquide péritonéal sont des indices de 
nécrose intestinale. Ces résultats montrent l’existence d’une activation des neutrophiles lors des pathologies intestinales étranglées et 
non-étranglées chez le cheval. La concentration de MPO dans le plasma et le liquide péritonéal peut être un indicateur de la gravité de la 
pathologie intestinale chez le cheval.
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proteases (e.g., elastase) and myeloperoxidase (MPO) (9), a hemic 
enzyme located in the azurophilic granules of the neutrophils. In 
addition to its peroxidase activity, MPO catalyzes the production of 
hypochlorous acid (HOCl), a strong oxidant, which contributes to 
bacterial destruction inside the phagolysosome of the neutrophil (9). 
Increased plasmatic MPO levels are a marker of neutrophil activation 
and degranulation in humans (9,10).
There are only a few studies of neutrophil activation in blood and 
MPO activity in the intestinal tissue of horses with naturally occur-
ring or experimentally induced acute abdominal disease (11,12). To 
our knowledge, no study has been conducted to date on the MPO 
concentration in the plasma and peritoneal fluid (PF) of horses with 
various types of acute abdominal disease. The aim of this work 
was to evaluate the MPO concentration in the systemic circulation 
and in the PF of horses with colic by means of a recently designed 
enzyme-linked immunosorbent assay (ELISA). The values would 
be compared with those obtained from healthy horses and related 
to disease process and outcome. The hypothesis was that horses 
with strangulation obstruction or inflammatory bowel disease (IBD) 
would have higher MPO levels in plasma and PF than horses with 
nonstrangulating disease.
M a t e r i a l s  a n d  m e t h o d s
Horses
Included in the study were 103 horses admitted for acute 
abdominal disease to the Equine Clinic of the Faculty of Veterinary 
Medicine, University of Liège, Belgium, from December 2002 to 
June 2005. Clinical data were obtained from a review of the medical 
records. Only horses with gastrointestinal lesions were included. 
Demographic data such as age, sex, and breed were recorded for each 
horse. All the horses underwent a clinical and rectal examination as 
well as nasogastric intubation on admission. Blood was drawn to 
determine packed cell volume, blood gas levels, leukocyte count, 
and biochemical profile. In 42 cases the clinical condition also per-
mitted the sampling of sufficient PF for analysis. After examination, 
the horses were treated medically or surgically by ventral midline 
celiotomy, or euthanasia was performed (because of poor prognosis 
or because no surgery was permitted for financial reasons) and a 
necropsy done. The outcome of hospitalization was categorized as 
survival or nonsurvival. Horses euthanized for financial reasons 
were excluded from the survival analysis. The affected portion of 
the gastrointestinal tract and the disease process (obstruction or 
tympany, strangulation obstruction, IBD, or peritonitis) were identi-
fied. The final diagnosis was categorized as nonstrangulating large 
intestinal lesion (NSLI, group 1), strangulating large intestinal lesion 
(SLI, group 2), strangulating small intestinal lesion (SSI, group 3), 
or inflammatory bowel disease (IBD, group 4), which included 
various conditions, such as typhlocolitis, proximal enteritis, and 
peritonitis.
For a comparison group of heathy horses, we used a control group 
of 38 horses whose plasma MPO values had been determined in an 
earlier study (13). All belonged to the herd of the veterinary faculty 
and the center for locomotion research at Mont-le-Soie, Belgium, and 
had been found to be healthy by physical examination. We obtained 
PF from 17 of the horses: 10 warmblood and 7 draught horses aged 
2 to 19 y; 7 were females, 3 males, and 7 geldings.
Blood and PF sampling technique
Blood samples were collected into tubes containing ethylene 
diamine tetraacetic acid (EDTA) upon admission of the horses to 
the clinic and immediately centrifuged for 10 min at 1000 3 g. 
The plasma was stored at 220°C until the MPO assay. The PF was 
sampled by needle or cannula puncture at the lowest point of the 
abdomen, near the ventral midline. In the presence of abdominal 
distension, ultrasonography was used to locate the PF. It was col-
lected into tubes containing EDTA and centrifuged for 10 min at 
1000 3 g. Small aliquots of the supernatant were stored at 220°C 
until the MPO assay.
Assay of MPO in plasma and PF
The centrifuged plasma and PF samples were diluted 40 times 
in 20 mM phosphate-buffered saline (pH 7.4) containing 5 g/L of 
bovine serum albumin and 0.1% Tween 20. The MPO concentrations 
were determined, with reference to a standard curve, by means of an 
original ELISA, as previously described (13), with the use of 2 spe-
cific polyclonal antibodies obtained from rabbit (primary antibody) 
and guinea pig (secondary antibody). The “sandwich complex” 
primary antibody–MPO–secondary antibody was recognized by a 
goat antibody to guinea pig immunoglobulin coupled to alkaline 
phosphatase. Phosphatase activity was detected by incubation (for 
30 min at 37°C in the dark) with a paranitrophenyl phosphate solu-
tion (phosphatase substrate). The reaction was stopped with 2.5 M 
NaOH and the absorbance at 405 nm read with the Multiscan Ascent 
spectrophotometer (Thermo Labsystems, Helsinki, Finland).
The standard curve was established with known concentrations of 
purified equine MPO ranging from 0.78 to 50 ng/mL. The assay had 
previously been validated with equine blood and plasma (13,14).
Statistical analysis
All data were obtained in triplicate, and results of calculations are 
reported as means (and standard deviation). The previously obtained 
mean plasma concentration for healthy horses was 181.8 (64.74) 
ng/mL (13). A maximum physiological value of 376 ng/mL (mean 
1 3 standard deviations) was determined to ensure a probability of 
error lower than 0.01% in determining abnormally high values. For 
each group the percentage of horses that showed MPO values above 
the maximum was determined.
The data were analyzed by Kruskal–Wallis nonparametric analysis 
of variance with Dunn’s multiple-comparison post-test (comparison 
of mean plasma MPO values between the 4 disease groups and 
the control group). For comparisons of only 2 groups, we used 
an unpaired t test with the Welch correction (comparison of mean 
plasma MPO values between horses with or without shock signs 
and between survivors and nonsurvivors, as well as comparison of 
mean PF MPO values between the control group and groups 2, 3, 
and 4 together). The relation between plasma MPO value and total 
leukocyte count was tested by determining the Pearson correlation 
coefficient (r). A P-value of less than 0.05 was considered significant. 
All statistical analyses were performed with the GraphPad InStat 3.05 
program (GraphPad Software, San Diego California, USA).
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R e s u l t s
Among the 103 horses admitted to the clinic, 70 (68%) were of the 
warmblood breed, a frequency similar to that in the general hospital 
population. The other horses consisted of 13 ponies, 5 Appaloosas, 
4 thoroughbreds, 4 draught horses, 3 Arabians, 2 standardbreds, and 
2 Andalusians. There were 49 castrated males (48%), 48 mares (47%), 
and 6 sexually intact males (6%). Their age ranged from 1 to 27 y, 
with a mean of 10.6 (6.1) y and a median of 9 y. Their weight varied 
from 251 to 790 kg. Although 56 horses survived to discharge, 
47 horses were euthanized after admission owing to severe shock 
signs or reasons other than medical, during surgery because the 
lesions were inoperable or too extensive, or during the postopera-
tive phase. The 14 horses euthanized for nonmedical reasons were 
excluded from the survival analysis.
Of the 38 horses with an NSLI (group 1), 14 had displacement 
in the renosplenic space, 13 impaction colic of the pelvic flexure, 
7 other displacements of the ascending colon, and 4 cecal tympany. 
Of the 21 horses with an SLI (group 2), 18 had complete large colon 
torsion or volvulus, and 1 horse each had cecal torsion, cecocolic 
intussusception, or strangulating lipoma of the descending colon. 
Of the 32 horses with an SSI, 17 had incarcerated jejunum or ileum 
in the epiploic foramen, 7 jejunal volvulus, 5 a strangulating lipoma, 
1 a diaphragmatic hernia, 1 ileocecal intussusception, and 1 ileal 
impaction with jejunal volvulus. Of the 12 horses with various 
inflammatory or infectious bowel and peritoneal diseases (group 4), 
5 had typhlocolitis (combined with proximal enteritis in 1 horse), 
4 proximal enteritis, and 3 peritonitis.
The mean plasma MPO value was 343.16 (260.81) ng/mL (range 76 
to 1099 ng/mL) for the horses with an NSLI, significantly different 
(2-tailed P = 0.0006; Welch’s approximate t = 3.702 with 41 degrees 
of freedom [df]) from the mean for the healthy controls, 181.8 (64.74) 
ng/mL. For the horses in groups 2, 3, and 4, the mean plasma MPO 
values were even higher, at 1176.38 (755.74) ng/mL (range 567.12 to 
2975.20 ng/mL), 733.28 (505.36) ng/mL (range 164 to 1993 ng/mL), 
and 1206.8 (906.97) ng/mL (range 365 to 3670 ng/mL), respectively, 
and were significantly higher than the means for the healthy controls 
and group 1 (P , 0.01) (Figure 1). Plasma MPO values above the 
physiological maximum of 376 ng/mL were obtained for 34%, 76%, 
75%, and 92% of the horses in groups 1 to 4, respectively. No correla-
tion was observed between the total blood leukocyte count and the 
MPO value in any of the groups evaluated (Figure 2).
In the NSLI group, only 2 horses (5%) showed signs of endotoxic 
shock, whereas 13 (62%) of the SLI group and 19 (59%) of the SSI 
group showed signs of shock. In all horses showing signs of endo-
toxic shock, the plasma MPO values were above the maximum physi-
ological value. The mean MPO value was 379.04 (291.28) ng/mL in 
the 57 horses without signs of shock, whereas it was 1236.4 (759.72) 
ng/mL in the 35 horses with signs of shock (P , 0.0001).
Survival analysis was performed with groups 1 to 3 but without 
the 14 horses that were euthanized because financial constraints 
precluded surgery or enterectomy. Of the remaining 77 horses, 
47 survived to discharge. The mean plasma MPO value was sig-
nificantly higher (P , 0.0001) in the nonsurvivor group than in the 
survivor group, at 1199.23 (644.87) versus 391 (295.78) ng/mL. In 
the nonsurvivor group, all horses except 1 had plasma MPO values 
above the physiological maximum, whereas only 18 of the horses in 
the survivor group had such values.
The mean MPO value obtained with 17 PF samples from healthy 
horses was 338.66 (178.66) ng/mL (range 101.84 to 761.16 ng/mL). 
For the horses in groups 1 to 4 whose PF was sampled, the mean 
MPO values were 181 (112.18) ng/mL (range 74 to 339 ng/mL) 
for the 4 horses with NSLI, 1193.6 (818.08) ng/mL (range 88 to 
2178 ng/mL) for the 5 horses with SLI, 1169.46 (955.99) ng/mL 
(range 107 to 2893 ng/mL) for the 24 horses with SSI, and 1137.78 
(686.01) ng/mL (range 72 to 2204 ng/mL) for the 9 horses with IBD. 
Table I shows the plasma and PF MPO values of these 42 horses, as 
well as respective pathological and clinical details.
Owing to the low numbers of PF samples in the large-intestine 
groups, we amalgamated the data for the 4 groups and obtained 
a mean of 1071.4 (869.7) ng/mL for these 42 samples, which was 
significantly higher (2-tailed P , 0.0001; Welch’s approximate 



















Figure 1. Mean plasma concentrations of myeloperoxidase (MPO) (and 
standard deviation) in the control group of healthy horses and 4 groups of 
horses with gastrointestinal disease. NSLI — nonstrangulating obstruction 
of the large intestine; SLI — strangulating obstruction of the large intestine; 
SSI — strangulating obstruction of the small intestine; IBD — inflammatory 
bowel disease. Asterisks indicate a significant difference from the control 
mean, at P , 0.05, and number signs a significant difference from the 



















Figure 2. Lack of correlation between the plasma MPO value and the total 
blood leukocyte count (3 109/L) in the 4 groups of horses with gastro­
intestinal disease: r = 20.1485 (not significant).
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Table I. Pathological and clinical details, as well as plasma and peritoneal 
fluid (PF) concentrations of myeloperoxidase (MPO), for 42 horses with 
gastrointestinal disease
 MPO level 
 (ng/mL)
Diseasea Lived Shockb Necrosisc Plasma PF
NSLI
RS entrapment Yes 2 2 175 339
Impaction Yes 2 2 188 74
Cecal tympany Yes 2 2 396 160
Cecal tympany Yes 2 2 331 151
SLI
CC intuss. No 2 111 830 1464
ACT No 111 111 1359 1567
ACT No 11 111 1825 2178
ACT No 111 111 1431 671
ACT Yes 2 2 339 88
SSI
IEF Yes 2 11 218 107
IEF Yes 2 11 335 484
IEF No 111 111 871 2365
IEF No 111 111 963 2390
IEF No 2 111 478 2748
IEF No 11 11 1895 505
IEF No 111 111 806 2893
IEF No 2 11 1075 867
IEF No 111 111 479 714
IEF No 11 11 935 443
IEF No 2 11 188 251
IEF No 2 11 213 774
IEF No 11 11 352 489
IEF No 111 111 1743 2177
S lipoma Yes 2 111 253 883
S lipoma No 2 111 423 477
S lipoma No 11 111 611 2048
S lipoma No 111 111 1993 2580
S lipoma No 111 111 1778 2355
Volvulus No 11 11 665 531
Volvulus No 11 11 654 209
Volvulus No 2 11 221 418
Ileal imp., volvulus Yes 2 2 1059 371
D hernia No 111 111 1044 988
IBD
P enteritis Yes 2 NA 628 72
P enteritis Yes 11 NA 3670 477
P enteritis Yes 11 NA 365 1892
Typhlocolitis Yes 2 NA 1152 958
Typhlocolitis No 111 NA 1297 807
Peritonitis No 111 NA 393 1031
Peritonitis Yes 11 NA 1203 2204
Peritonitis Yes 111 NA 1767 1713
Colitis, enteritis No 11 NA 982 1086
a NSLI — nonstrangulating obstruction of the large intestine; RS — renosplenic; 
SLI — strangulating obstruction of the large intestine; CC intuss. — cecocolic 
intussusception; ACT — ascending colon torsion; SSI — strangulating obstruc-
tion of the small intestine; IEF — incarceration of the jejunum and/or ileum into 
the epiploic foramen; S — strangulating; imp. — impaction; D — diaphragmatic; 
IBD — inflammatory bowel disease; P — proximal.
b Signs of endotoxic shock: none (2), moderate (11), or severe (111).
c Intestinal necrosis: none (2), moderate (11), severe (111), or not applicable 
(NA).
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When we compared the horses of the SSI group having severe 
intestinal necrosis (n = 12) with the horses without or with moder-
ate vascular lesions (no enterectomy necessary; n = 10), a significant 
difference in MPO content was found (P , 0.0002; Welch’s approxi-
mate t = 5.423 with 12 df). In 8 of the 12 horses, the MPO values 
in PF were particularly high. The mean MPO concentration in the 
PF of the horses with severe necrosis was 1884.8 (864.68) ng/mL, 
whereas it was 485.8 (206.06) ng/mL for the horses with moderate 
vascular lesions.
D i s c u s s i o n
The study reported here reveals that neutrophil activation occurs 
in a high percentage of horses with intestinal obstruction, espe-
cially strangulating obstruction, and that MPO is released into 
the plasma as well as the PF. Likewise, in a prior study, horses 
with SLI showed the highest plasma MPO values (15). In cases 
of experimental low-flow ischemia of the large colon, accumula-
tion of neutrophils in the colonic mucosa as well as increased 
MPO concentrations have previously been demonstrated (7,16). 
The large colon contains more endotoxin than the small intestine. 
The toxin enters the systemic circulation owing to permeability 
changes during strangulating obstruction and can directly activate 
the neutrophils (5). The large number of resident neutrophils in 
the colonic mucosa can also contribute to the higher MPO values. 
Furthermore, we observed increased MPO values in IBD, confirming 
the recent observation of increased serum amyloid A, an acute-phase 
protein, in horses with IBD (17). More cases should be evaluated to 
confirm whether animals with IBD show higher MPO values than 
those with strangulating lesions. This could be an interesting new 
element in differentiating proximal enteritis from small intestinal 
obstruction.
In our study, horses with NSLI, especially those with large- 
intestine displacement and severe tympany, had higher plasma 
MPO values than healthy horses. This finding is in contrast to the 
lack of observed neutrophil activation in nonstrangulated colic cases 
in another study (12). Sequestration of fluid and severe intestinal 
distension can lead to hypovolemic shock and could activate neu-
trophils, resulting in an increase in MPO concentration.
Owing to the high variability of MPO levels, we could not establish 
a cut-off point to distinguish survivors from nonsurvivors. A larger 
study should be conducted. Additionally, postoperative  follow-up 
could show that in some cases MPO values return to normal rapidly 
in surviving horses, as has been shown previously (15).
Studies of the prognostic and diagnostic value of PF in acute 
abdominal disease have shown that color and specific gravity or total 
protein concentration are more valuable than nucleated cell count 
for establishing prognosis or lesion type (18,19). In our study, the 
presence of high MPO levels in the PF in strangulating obstruction 
indicated necrotic bowel and a poor prognosis. Interestingly, the 
MPO level is not correlated with the neutrophil count. Activated 
neutrophils may degranulate and disappear rapidly, so that only the 
proteases are left. High PF MPO content is more indicative of SSI 
than is a high plasma MPO level. Similarly, a recent study showed 
that the PF lactate level was a better predictor of a strangulating 
lesion than was the plasma lactate level (20).
Recent studies have shown the implication of neutrophil activation 
in noninfectious diseases such as paralytic ileus (21) and laminitis 
(22,23) occurring as complications of strangulating obstruction in 
horses. Indeed, excessive neutrophil activation and degranulation 
could release active MPO as well as other proteases into the blood 
stream or tissues. Beyond its antimicrobial activity, MPO shows 
cytotoxicity towards erythrocytes and endothelial cells (24,25). It 
can also lead to platelet activation and enzyme inactivation. By 
inactivating antiproteases and activating proteases, MPO may also 
disturb the coagulation and protease/antiprotease balance (26). This 
could contribute to the development of postoperative complications. 
Another method is being developed to assay active MPO specifically 
(27). In this way, the implication of MPO in various pathological 
mechanisms could be defined. Inhibitors of MPO could be developed 
to modulate inflammation.
In conclusion, equine intestinal diseases are linked to the activa-
tion of neutrophils in the systemic circulation as well as in the peri-
toneal cavity. The MPO assay could therefore be useful in predicting 
the severity of the disease.
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